微創胸腔外科手術市場－全球產業規模、佔有率、趨勢、機會和預測：按類型（肺葉切除術、楔形切除術、全肺切除術、其他）、區域和競爭格局分類，2021-2031年

全球微創胸腔外科手術市場預計將從 2025 年的 42.5 億美元大幅成長至 2031 年的 59.9 億美元，複合年成長率為 5.89%。

該市場涵蓋了先進的外科技術，例如胸腔鏡輔助手術（VATS）和機器人輔助胸腔鏡手術（RATS），這些技術透過微小切口來診斷和治療各種肺部和縱隔疾病。推動這一市場成長的主要因素是胸部惡性腫瘤發生率的上升以及改善術後療效的迫切臨床需求。這些需求源於患者希望縮短住院時間、減輕身體負擔和加速康復，所有這些都有助於提高醫療效率。

該外科領域的顯著擴張清晰地體現在專業機構追蹤的大量臨床數據中。例如，根據胸腔外科醫師協會的報告，其一般胸腔外科手術資料庫到2024年累積病例將接近一百萬例，凸顯了手術活動的巨大規模。儘管發展迅猛，但機器人系統的引進和持續維護成本高昂，仍是市場普及的主要障礙。這些巨大的經濟負擔往往阻礙了資源匱乏的醫療機構採用先進的手術平台，從而限制了患者接受這些尖端手術的機會。

市場促進因素

視訊輔助和機器人輔助手術技術的快速發展正在從根本上改變胸腔外科領域。這些技術顯著提高了手術精度，並能透過更小的切口完成複雜的切除手術。這些創新直接滿足了減輕患者負擔的臨床需求，因此被許多醫療機構廣泛採用，這些機構渴望最佳化手術流程並確保治療效果的一致性。機器人平台在切除術和楔形切除術等手術中的應用日益廣泛，凸顯了這項變革對臨床實踐的影響。例如，根據Intuitive Surgical公司2024年第三季財報，全球整體達文西手術量年增約18%，主要得益於胸腔外科手術的強勁成長動能。這一成長表明，先進的機器人系統正迅速融入標準臨床實踐，並在現代醫療環境中逐步取代傳統的開胸手術。

同時，胸部惡性腫瘤發生率的上升是推動市場規模成長的關鍵因素，因此，高效且擴充性的外科手術介入對於應對日益增多的患者至關重要。隨著醫療機構優先考慮早期療育以提高長期存活率，癌症診斷數量上升與外科治療需求之間的直接關係日益密切。根據美國癌症協會發布的《2024年癌症事實與數據》，預計僅在美國就將新增約234,580例肺癌病例，凸顯了需要外科治療的巨大疾病負擔。此外，肺癌篩檢計畫的擴展有效地識別出更多適合在早期可治療階段接受手術的患者。美國肺臟協會發布的《2024年肺癌狀況》報告顯示，目標族群的全國平均篩檢率為16.0%，這意味著有望從微創根治性手術中獲益的患者群體正在不斷擴大。

市場挑戰

機器人系統的高昂初始投資和持續維護成本構成了全球微創胸腔外科市場擴張的重大結構性障礙。這些先進平台需要大量的初始投資，這往往超出了小規模區域醫院和門診手術中心的財力。除了初始購置成本外，持續營運成本，包括強制性服務合約、專用一次性器材和必要的軟體更新，也給醫療機構帶來了沉重的長期財務負擔。這種財務負擔有效地阻礙了機器人輔助胸腔鏡手術的廣泛應用，使其主要局限於資金雄厚的大型大學醫院，並迫使許多潛在患者只能依賴傳統手術方式。

這些財務障礙對現代醫院的採購模式產生了顯著影響。當醫療機構面臨預算限制時，昂貴的資本設備往往首當其沖地被凍結採購。根據美國醫院協會 (AHA) 2024 年的一項調查，約 94% 的醫療機構管理者表示，他們打算推遲設備升級和基礎設施投資，以應對持續的財務挑戰。這種普遍推遲資本投資的做法直接抑制了機器人系統的銷售勢頭，導致市場成長放緩，儘管臨床上對改善患者預後的需求十分明確。

市場趨勢

單孔機器人手術平台的日益普及正在從根本上改變胸腔外科手術的方式，顯著降低了複雜切除手術的創傷性。與需要多個肋間切口的傳統多孔手術不同，單孔系統允許外科醫生透過一個微小切口完成切除術和胸腺切除術等複雜手術，從而大大減少肋間神經壓迫和術後神經痛的發生。隨著醫療機構優先考慮那些能夠改善美容效果、促進患者早期出院並同時保持腫瘤療效的技術，這種結構性轉變正迅速被接受。專業機構對新世代平台的日益普及凸顯了此方法的強勁市場動能。例如，Intuitive Surgical公司2025年第三季公佈財報，使用達文西SP系統進行的手術量較去年同期成長了91%，這主要得益於其應用範圍的擴大，尤其是在胸腔外科和結直腸外科領域。

同時，人工智慧（AI）在術前規劃和導航中的應用，有效解決了周邊肺結節診斷的難題。先進的AI演算法能夠將2D電腦斷層掃描轉化為高度精細的3D解剖模型，從而實現對支氣管路徑的精確定位，這對於導航支氣管鏡檢查和亞肺葉切除術至關重要。這項數位技術的進步超越了傳統的支氣管鏡檢查技術，透過提供基於電腦的即時導航，提高了診斷準確性，並促進了對以往難以觸及的病灶的早期治療性介入。這些底層技術的顯著成長，清楚地顯示了臨床對這類智慧導航生態系統的需求。根據Intuitive Surgical公司2024年第四季公佈財報，AI驅動的Ion Lumen系統的使用率年增約70%，凸顯了計算精度在現代胸腔外科醫學中的關鍵作用。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球微創胸腔外科市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 按類型（切除術、楔形切除術、全肺切除術、其他）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美微創胸腔外科市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲微創胸腔外科市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區微創胸腔外科市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲微創胸腔外科手術市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲微創胸腔外科市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球微創胸腔外科市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Intuitive Surgical
• Medtronic
• Stryker
• Karl Storz
• Olympus
• Richard Wolf
• CONMED
• Boston Scientific
• LivaNova

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Minimally Invasive Thoracic Surgery Market is projected to expand significantly, from USD 4.25 Billion in 2025 to USD 5.99 Billion by 2031, demonstrating a Compound Annual Growth Rate (CAGR) of 5.89%. This market encompasses advanced surgical techniques like Video-Assisted Thoracic Surgery (VATS) and Robotic-Assisted Thoracic Surgery (RATS), which utilize small incisions to diagnose and treat various pulmonary and mediastinal conditions. The primary catalysts for this growth are the increasing incidence of thoracic malignancies and the compelling clinical need to enhance postoperative results, driven by patient demand for shorter hospital stays, reduced trauma, and quicker recovery, all contributing to improved healthcare efficiency.

The substantial expansion of this surgical domain is clearly reflected in the extensive volume of clinical data tracked by professional organizations; for instance, the Society of Thoracic Surgeons reported that its General Thoracic Surgery Database reached nearly one million cumulative case records in 2024, highlighting the vast scale of surgical activity. Despite this growth, a significant obstacle to broader market adoption is the considerable expense associated with the acquisition and ongoing maintenance of robotic systems. These substantial financial barriers frequently impede the implementation of advanced surgical platforms in healthcare environments with limited resources, subsequently constraining patient access to these modern procedures.

Market Driver

The thoracic surgery landscape is undergoing a fundamental transformation due to swift progress in video-assisted and robotic-assisted surgical technologies, which significantly enhance surgical precision and facilitate intricate resections through smaller incisions. These technological innovations directly address the clinical imperative for reduced patient trauma, thereby fostering wider adoption among healthcare facilities keen on optimizing surgical workflows and ensuring consistent patient outcomes. The operational impact of this shift is underscored by the growing use of robotic platforms for procedures such as lobectomies and wedge resections; for example, Intuitive Surgical's Q3 2024 earnings report indicated an approximate 18% year-over-year increase in worldwide da Vinci procedures, largely propelled by momentum in general thoracic applications. This surge illustrates the rapid integration of advanced robotic systems into standard care, progressively displacing traditional open thoracotomy techniques in contemporary healthcare.

Concurrently, the escalating prevalence of thoracic malignancies represents a crucial factor driving market volume, necessitating efficient and scalable surgical interventions to manage the increasing patient caseload. The direct relationship between rising cancer diagnoses and the demand for surgical treatment is intensifying as healthcare providers place a high priority on early intervention to improve long-term survival rates. Data from the American Cancer Society's 'Cancer Facts & Figures 2024' projected approximately 234,580 new lung cancer diagnoses in the United States alone, highlighting the considerable disease burden requiring surgical management. Moreover, the expansion of lung cancer screening programs is effectively identifying a greater number of surgical candidates at earlier, more treatable stages; the American Lung Association's 'State of Lung Cancer 2024' report noted a national average screening rate of 16.0% among eligible individuals, signifying a growing pipeline of patients likely to benefit from minimally invasive curative procedures.

Market Challenge

The substantial acquisition and ongoing maintenance costs associated with robotic systems represent a formidable structural impediment to the expansion of the Global Minimally Invasive Thoracic Surgery Market. These sophisticated platforms demand significant initial capital investment, often surpassing the financial capacities of smaller regional hospitals and ambulatory surgical centers. Beyond the upfront purchase price, the sustained operational expenses, including mandatory service agreements, specialized single-use instruments, and essential software updates, impose a considerable long-term financial obligation on healthcare institutions. This economic burden effectively prevents the widespread adoption of robotic thoracic surgery, largely confining its availability to major, well-resourced academic medical centers and leaving numerous potential patients reliant on conventional surgical techniques.

The discernible impact of these financial obstacles is evident in contemporary hospital procurement patterns. When healthcare facilities encounter budgetary restrictions, high-cost capital equipment frequently becomes the first category subject to procurement freezes. According to the American Hospital Association in 2024, an estimated 94% of healthcare administrators indicated their intention to postpone equipment upgrades and infrastructure investments in response to persistent fiscal challenges. This widespread deferral of capital expenditure directly constrains the sales momentum of robotic systems, consequently moderating the market's growth trajectory despite a clear clinical need for improved patient outcomes.

Market Trends

The increasing adoption of Single-Port Robotic Surgical Platforms is fundamentally reshaping thoracic interventions by significantly reducing the invasiveness of complex resections. Unlike conventional multiportal approaches that necessitate multiple intercostal incisions, single-port systems enable surgeons to perform intricate procedures such as lobectomies and thymectomies through a singular small entry point, thereby substantially diminishing intercostal nerve compression and postoperative neuralgia. This architectural shift is rapidly gaining acceptance as healthcare providers prioritize technologies that improve cosmetic results and expedite patient discharge, all while maintaining oncological effectiveness. The market's strong momentum for this modality is underscored by the escalating use of next-generation platforms in specialized centers; for instance, Intuitive Surgical's Q3 2025 earnings call reported a 91% year-over-year increase in da Vinci SP system procedures, notably driven by its expanded application in thoracic and colorectal surgeries.

Simultaneously, the integration of Artificial Intelligence (AI) for Surgical Planning and Navigation is effectively addressing the diagnostic difficulties associated with peripheral pulmonary nodules. Advanced AI algorithms now transform 2D CT scans into highly detailed 3D anatomical models, allowing for the precise mapping of bronchial pathways crucial for navigational bronchoscopy and sub-lobar resections. This digital advancement extends beyond standard bronchoscopic techniques by providing real-time, calculated guidance to lesions that were previously challenging to access, consequently enhancing diagnostic yields and facilitating earlier therapeutic interventions. The clinical demand for such intelligent navigational ecosystems is clearly demonstrated by the considerable growth of these enabling technologies; according to Intuitive Surgical's Fourth Quarter 2024 earnings release, the utilization of the AI-driven Ion endoluminal system increased by approximately 70% compared to the previous year, emphasizing the essential role of computational precision in contemporary thoracic care.

Key Market Players

• Intuitive Surgical
• Medtronic
• Stryker
• Karl Storz
• Olympus
• Richard Wolf
• CONMED
• Boston Scientific
• LivaNova

Report Scope

In this report, the Global Minimally Invasive Thoracic Surgery Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Minimally Invasive Thoracic Surgery Market, By Type

• Lobectomy
• Wedge Resection
• Pneumonectomy
• Others

Minimally Invasive Thoracic Surgery Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Minimally Invasive Thoracic Surgery Market.

Available Customizations:

Global Minimally Invasive Thoracic Surgery Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Minimally Invasive Thoracic Surgery Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Lobectomy, Wedge Resection, Pneumonectomy, Others)
  • 5.2.2. By Region
  • 5.2.3. By Company (2025)
• 5.3. Market Map

6. North America Minimally Invasive Thoracic Surgery Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Minimally Invasive Thoracic Surgery Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
  • 6.3.2. Canada Minimally Invasive Thoracic Surgery Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
  • 6.3.3. Mexico Minimally Invasive Thoracic Surgery Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type

7. Europe Minimally Invasive Thoracic Surgery Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Minimally Invasive Thoracic Surgery Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
  • 7.3.2. France Minimally Invasive Thoracic Surgery Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
  • 7.3.3. United Kingdom Minimally Invasive Thoracic Surgery Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
  • 7.3.4. Italy Minimally Invasive Thoracic Surgery Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
  • 7.3.5. Spain Minimally Invasive Thoracic Surgery Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type

8. Asia Pacific Minimally Invasive Thoracic Surgery Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Minimally Invasive Thoracic Surgery Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
  • 8.3.2. India Minimally Invasive Thoracic Surgery Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
  • 8.3.3. Japan Minimally Invasive Thoracic Surgery Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
  • 8.3.4. South Korea Minimally Invasive Thoracic Surgery Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
  • 8.3.5. Australia Minimally Invasive Thoracic Surgery Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type

9. Middle East & Africa Minimally Invasive Thoracic Surgery Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Minimally Invasive Thoracic Surgery Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
  • 9.3.2. UAE Minimally Invasive Thoracic Surgery Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
  • 9.3.3. South Africa Minimally Invasive Thoracic Surgery Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type

10. South America Minimally Invasive Thoracic Surgery Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Minimally Invasive Thoracic Surgery Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
  • 10.3.2. Colombia Minimally Invasive Thoracic Surgery Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
  • 10.3.3. Argentina Minimally Invasive Thoracic Surgery Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Minimally Invasive Thoracic Surgery Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Intuitive Surgical
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Medtronic
• 15.3. Stryker
• 15.4. Karl Storz
• 15.5. Olympus
• 15.6. Richard Wolf
• 15.7. CONMED
• 15.8. Boston Scientific
• 15.9. LivaNova

16. Strategic Recommendations

17. About Us & Disclaimer